JP2005514452A - フェニル（アルキル）カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび／または血清脂質低下活性を有する医薬としての使用 - Google Patents

フェニル（アルキル）カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび／または血清脂質低下活性を有する医薬としての使用 Download PDF

Info

Publication number
JP2005514452A
JP2005514452A JP2003559969A JP2003559969A JP2005514452A JP 2005514452 A JP2005514452 A JP 2005514452A JP 2003559969 A JP2003559969 A JP 2003559969A JP 2003559969 A JP2003559969 A JP 2003559969A JP 2005514452 A JP2005514452 A JP 2005514452A
Authority
JP
Japan
Prior art keywords
ethoxy
dimethyl
malonate
benzyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003559969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514452A5 (enExample
Inventor
ファビオ・ジャンネッシ
エマヌエラ・タッソーニ
ナタリナ・デッルオーモ
ティツィアナ・ブルネッティ
マリア・オルネッラ・ティンティ
アルドゥイーノ・アルドゥイーニ
ポンペオ・ペッソット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2005514452A publication Critical patent/JP2005514452A/ja
Publication of JP2005514452A5 publication Critical patent/JP2005514452A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/48—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
JP2003559969A 2002-01-15 2003-01-13 フェニル（アルキル）カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび／または血清脂質低下活性を有する医薬としての使用 Pending JP2005514452A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000016A ITRM20020016A1 (it) 2002-01-15 2002-01-15 Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
PCT/IT2003/000007 WO2003059864A2 (en) 2002-01-15 2003-01-13 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity

Publications (2)

Publication Number Publication Date
JP2005514452A true JP2005514452A (ja) 2005-05-19
JP2005514452A5 JP2005514452A5 (enExample) 2006-03-02

Family

ID=11455958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003559969A Pending JP2005514452A (ja) 2002-01-15 2003-01-13 フェニル（アルキル）カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび／または血清脂質低下活性を有する医薬としての使用

Country Status (14)

Country Link
US (1) US20050032787A1 (enExample)
EP (1) EP1465858A2 (enExample)
JP (1) JP2005514452A (enExample)
KR (1) KR100969979B1 (enExample)
CN (1) CN100509783C (enExample)
AR (1) AR038147A1 (enExample)
AU (1) AU2003209676B2 (enExample)
BR (1) BR0306880A (enExample)
CA (1) CA2472209A1 (enExample)
IT (1) ITRM20020016A1 (enExample)
MX (1) MXPA04006802A (enExample)
PL (1) PL372616A1 (enExample)
TW (1) TW200302737A (enExample)
WO (1) WO2003059864A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
CA2535665A1 (en) * 2003-08-14 2005-02-24 Asahi Kasei Pharma Corporation Substituted arylalkanoic acid derivative and use thereof
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
WO2006029575A1 (fr) * 2004-09-17 2006-03-23 Institute Of Mataria Medica, Chinese Academy Of Medical Sciences Nouveaux acides $g(a)-alkyloxy propioniques, leurs procedes de preparation, compositions pharmaceutiques les contenant et leurs utilisations
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
TW200724138A (en) * 2005-03-29 2007-07-01 Sk Corp Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
EP1871735B1 (de) 2005-04-19 2015-12-23 Merck Patent GmbH Antioxidantien
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US7732475B2 (en) 2005-07-14 2010-06-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP2006271A4 (en) * 2006-03-30 2011-08-10 Asahi Kasei Pharma Corp SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF
EP2620431A1 (en) * 2006-07-20 2013-07-31 Asahi Kasei Pharma Corporation Novel crystals of substituted phenylalkanoic acid and production process
WO2009039944A1 (de) * 2007-09-21 2009-04-02 Sanofi-Aventis Phenothiazin derivate mit doppelbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JP5427784B2 (ja) * 2007-09-21 2014-02-26 サノフイ （カルボキシルアルキレン−フェニル）−フェニル−オキサルアミド、その製造方法、及び薬剤としてのその使用
JP5301468B2 (ja) * 2008-01-18 2013-09-25 旭化成ファーマ株式会社 安定な医薬組成物
AU2009241038B2 (en) 2008-04-28 2011-12-22 Asahi Kasei Pharma Corporation Phenylpropionic acid derivative and use thereof
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
WO2013059215A1 (en) 2011-10-17 2013-04-25 Biotheryx, Inc. Substituted biaryl alkyl amides
CN107858326B (zh) * 2017-12-12 2021-08-20 上海银海圣生物科技有限公司 小鼠前脂肪细胞3t3-l1的诱导分化剂及诱导分化方法

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52116431A (en) * 1976-03-24 1977-09-29 Nippon Nohyaku Co Ltd Phthalaminoic acid esters
US4108632A (en) * 1976-12-22 1978-08-22 Monsanto Company Use of phthalanilic acids to regulate the growth of corn plants
EP0008203A1 (en) * 1978-08-04 1980-02-20 Takeda Chemical Industries, Ltd. Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same
EP0193256A1 (en) * 1985-01-19 1986-09-03 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and use
US4788054A (en) * 1986-07-11 1988-11-29 Stepan Company N-phenylphthalisomides as ultraviolet radiation absorbers
WO1991019702A1 (en) * 1990-06-14 1991-12-26 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
JPH0592960A (ja) * 1991-02-25 1993-04-16 Kyorin Pharmaceut Co Ltd チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
US5232945A (en) * 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
JPH05213913A (ja) * 1991-08-20 1993-08-24 Adir 新規な２，４−チアゾリジンジオン化合物およびこれらの化合物を含有する医薬組成物
JPH0641069A (ja) * 1992-04-03 1994-02-15 Hoechst Roussel Pharmaceut Inc （１ｈ−インドール−１−イル）−２−（アミノ）アセトアミドおよび関連した（１ｈ−インドール−１−イル）−（アミノアルキル）アミド、中間体およびそれらの製法ならびに医薬としてのそれらの使用
JPH07330728A (ja) * 1994-04-11 1995-12-19 Sankyo Co Ltd 複素環化合物
WO1996038428A1 (en) * 1995-06-02 1996-12-05 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
JPH09169746A (ja) * 1995-12-18 1997-06-30 Kyorin Pharmaceut Co Ltd Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JPH09169709A (ja) * 1995-12-21 1997-06-30 Taisho Pharmaceut Co Ltd ヘテロアルキル置換フェニルアルキルアミン誘導体
JPH09301963A (ja) * 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JPH09323982A (ja) * 1996-04-03 1997-12-16 Japan Tobacco Inc プロピオン酸誘導体及びその用途
JPH10167965A (ja) * 1993-02-26 1998-06-23 Otsuka Pharmaceut Co Ltd メイラード反応阻害剤
WO1999000121A1 (en) * 1997-06-26 1999-01-07 Eli Lilly And Company Antithrombotic agents
JPH11510178A (ja) * 1995-08-04 1999-09-07 ゼネカ リミテッド ファルネシルトランスフェラーゼインヒビターとしての４−メルカプトピロリジン誘導体
WO1999062871A1 (en) * 1998-06-04 1999-12-09 Astrazeneca Ab New 3-aryl propionic acid derivatives and analogs
JP2000344748A (ja) * 1999-03-29 2000-12-12 Welfide Corp ３−芳香族置換プロピオン酸またはアクリル酸化合物
WO2000078312A1 (en) * 1999-06-18 2000-12-28 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
WO2001040170A1 (en) * 1999-12-03 2001-06-07 Astrazeneca Ab New phenalkyloxy-phenyl derivatives
JP2004516320A (ja) * 2000-12-23 2004-06-03 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｘａ因子阻害剤としてのオキシベンズアミド誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094900A (en) * 1977-05-19 1978-06-13 Smithkline Corporation Method of preparing aryloxybenzoic and arylthiobenzoic acids
CA2146701A1 (en) * 1994-04-11 1995-10-12 Takashi Fujita Heterocyclic compounds having anti-diabetic activity, their preparation and their use
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
CZ53699A3 (cs) * 1996-08-19 1999-07-14 Japan Tobacco Inc. Deriváty propionové kyseliny a jejich použití
IL158873A0 (en) * 2001-06-07 2004-05-12 Lilly Co Eli Modulators of peroxisome proliferator activated receptors

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52116431A (en) * 1976-03-24 1977-09-29 Nippon Nohyaku Co Ltd Phthalaminoic acid esters
US4108632A (en) * 1976-12-22 1978-08-22 Monsanto Company Use of phthalanilic acids to regulate the growth of corn plants
EP0008203A1 (en) * 1978-08-04 1980-02-20 Takeda Chemical Industries, Ltd. Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same
EP0193256A1 (en) * 1985-01-19 1986-09-03 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and use
US4788054A (en) * 1986-07-11 1988-11-29 Stepan Company N-phenylphthalisomides as ultraviolet radiation absorbers
JPH07149636A (ja) * 1990-06-14 1995-06-13 Pfizer Inc 血糖低下剤としての３−アリール−２−ヒドロキシプロピオン酸誘導体および同族体
WO1991019702A1 (en) * 1990-06-14 1991-12-26 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
JPH0592960A (ja) * 1991-02-25 1993-04-16 Kyorin Pharmaceut Co Ltd チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JPH05213913A (ja) * 1991-08-20 1993-08-24 Adir 新規な２，４−チアゾリジンジオン化合物およびこれらの化合物を含有する医薬組成物
JPH0641069A (ja) * 1992-04-03 1994-02-15 Hoechst Roussel Pharmaceut Inc （１ｈ−インドール−１−イル）−２−（アミノ）アセトアミドおよび関連した（１ｈ−インドール−１−イル）−（アミノアルキル）アミド、中間体およびそれらの製法ならびに医薬としてのそれらの使用
US5232945A (en) * 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
JPH10167965A (ja) * 1993-02-26 1998-06-23 Otsuka Pharmaceut Co Ltd メイラード反応阻害剤
JPH07330728A (ja) * 1994-04-11 1995-12-19 Sankyo Co Ltd 複素環化合物
WO1996038428A1 (en) * 1995-06-02 1996-12-05 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
JPH11510178A (ja) * 1995-08-04 1999-09-07 ゼネカ リミテッド ファルネシルトランスフェラーゼインヒビターとしての４−メルカプトピロリジン誘導体
JPH09169746A (ja) * 1995-12-18 1997-06-30 Kyorin Pharmaceut Co Ltd Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JPH09169709A (ja) * 1995-12-21 1997-06-30 Taisho Pharmaceut Co Ltd ヘテロアルキル置換フェニルアルキルアミン誘導体
JPH09323982A (ja) * 1996-04-03 1997-12-16 Japan Tobacco Inc プロピオン酸誘導体及びその用途
JPH09301963A (ja) * 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
WO1999000121A1 (en) * 1997-06-26 1999-01-07 Eli Lilly And Company Antithrombotic agents
WO1999062871A1 (en) * 1998-06-04 1999-12-09 Astrazeneca Ab New 3-aryl propionic acid derivatives and analogs
JP2000344748A (ja) * 1999-03-29 2000-12-12 Welfide Corp ３−芳香族置換プロピオン酸またはアクリル酸化合物
WO2000078312A1 (en) * 1999-06-18 2000-12-28 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
WO2001040170A1 (en) * 1999-12-03 2001-06-07 Astrazeneca Ab New phenalkyloxy-phenyl derivatives
JP2004516320A (ja) * 2000-12-23 2004-06-03 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｘａ因子阻害剤としてのオキシベンズアミド誘導体

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC ＆ MEDICINAL CHEMISTRY LETTERS, vol. 10, no. 21, JPN4007012991, 2000, pages 2453 - 2456, ISSN: 0000868958 *
BIOORGANIC ＆ MEDICINAL CHEMISTRY LETTERS, vol. 6, no. 10, JPN4007012990, 1996, pages 1145 - 1150, ISSN: 0000868957 *
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, JPN4007012989, 1982, JP, pages 3601 - 3616, ISSN: 0000868956 *
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 39, no. 6, JPN4007012988, 1991, JP, pages 1440 - 1445, ISSN: 0000868955 *
FARMACO, vol. 44(7-8), JPN6009030067, 1989, pages 721 - 729, ISSN: 0001348871 *
JOURNAL OF MEDICINAL CHEMISTRY, vol. 41, no. 11, JPN4007012987, 1998, US, pages 1927 - 1933, ISSN: 0000868954 *

Also Published As

Publication number Publication date
ITRM20020016A1 (it) 2003-07-15
CA2472209A1 (en) 2003-07-24
ITRM20020016A0 (it) 2002-01-15
MXPA04006802A (es) 2004-10-11
AU2003209676B2 (en) 2009-06-11
CN1617854A (zh) 2005-05-18
KR20040081107A (ko) 2004-09-20
PL372616A1 (en) 2005-07-25
KR100969979B1 (ko) 2010-07-15
WO2003059864A2 (en) 2003-07-24
US20050032787A1 (en) 2005-02-10
AU2003209676A1 (en) 2003-07-30
HK1076628A1 (en) 2006-01-20
AR038147A1 (es) 2004-12-29
BR0306880A (pt) 2004-12-21
WO2003059864A3 (en) 2004-01-29
TW200302737A (en) 2003-08-16
CN100509783C (zh) 2009-07-08
EP1465858A2 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
JP2005514452A (ja) フェニル（アルキル）カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび／または血清脂質低下活性を有する医薬としての使用
RU2328483C2 (ru) Индолы, обладающие противодиабетической активностью
DE60222006T2 (de) Heterozyklische verbindungen und ihre verwendungen
US20110195993A1 (en) Ppar agonist compounds, preparation and uses
JP5291708B2 (ja) アリールピリミジン誘導体、その製造方法、及び、その使用
JP2009537524A (ja) 抗糖尿病性の二環式化合物
CA2627363C (en) Compounds for the treatment of insulin resistance syndrome and diabetes
CA2500977A1 (en) 2-thiohydantoine derivative compounds and use thereof in therapeutics
DE60128239T2 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
CA3115297A1 (en) Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators
EP1572180B1 (en) Use of alpha-phenylthiocarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
US20090176841A1 (en) Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
Kumar et al. Design, synthesis and evaluation of carbazole derivatives as PPARα/γ dual agonists and antioxidants
JP4750556B2 (ja) 有効な抗高血糖活性および抗高脂血活性をもつＰＰＡＲｐａｎアゴニストとしての置換アリールアルカン酸誘導体
US7446127B2 (en) Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
JP2022542613A (ja) ヒトａｔｇｌの阻害剤
FR2866339A1 (fr) Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
JP2008535827A (ja) 糖尿病及び脂質障害の治療のための置換カルボン酸誘導体、それらの製造及び使用
WO2004113266A1 (en) Derivatives of phenylalkyl and phenoxyalkyl acids for the treatment of the hyperglycaemia and hypertriglyceridaemia and type 2 diabetes and process for preparing them
HK1076628B (en) Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
WO2011075935A1 (zh) 二苯基乙烯类衍生物及其用途
FR2880887A1 (fr) Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
HK1087007B (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
HK1129897A (en) Novel 6-5 bicycic heterocyclic derivative and medical use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070703

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20071003

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20071011

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20071105

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20071112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090918

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091023

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100506

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100906

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101020

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101116